Personalis, Inc. Common Stock (PSNL) is a publicly traded Healthcare sector company. As of September 21, 2026, PSNL trades at $16.39 with a market cap of $1.75B and a P/E ratio of -14.85. PSNL moved -1.04% today. Year to date, PSNL is +104.02%; over the trailing twelve months it is +166.23%. Its 52-week range spans $2.83 to $18.89. Analyst consensus is buy with an average price target of $15.95. Rallies surfaces PSNL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PSNL insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $16.39 |
| Market Cap | $1.75B |
| P/E Ratio | -14.85 |
| EPS | $-1.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.89 |
| 52-Week Low | $2.83 |
| Volume | 1.28M |
| Avg Volume | 0 |
| Revenue (TTM) | $69.67M |
| Net Income | $-107.18M |
| Gross Margin | 12.69% |
6 analysts cover PSNL: 0 strong buy, 2 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.95.